Vaecgene Biotech

Vaecgene Biotech GmbH is focuses on the research and development of novel therapeutics and in vitro diagnostics.

Vaecgene focuses on the research and development of novel therapeutics and in vitro diagnostics. Core competence and proprietary technology are the development of viral vectors that helped Vaecgene to establish a broad portfolio including individual drugs for immunological treatment of tumors and infectious diseases. Recently, Vaecgene has developed a new intelligent technology, AMIDA, for functional proteomics for fast and efficient identification and validation of tumor markers for early detection of cancer. In addition, the company offers services related to Epstein-Barr-Virus. The company has also extensive experience in monitoring and quantitating the immune competence in patients and non- human primates.